Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5536534 | Vaccine | 2017 | 9 Pages |
Abstract
Routine vaccination with TCV would be cost-effective in most settings, and additional one-time catch-up campaigns would also be economically justified.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marina Antillón, Joke Bilcke, A. David Paltiel, Virginia E. Pitzer,